Study Participation:

This study requires participants to attend 9 in-clinic visits over 7 months. To participate in this study, you will receive a vaccine. Those who are eligible and attend the in-clinic visits will receive $75.00 per visit to compensate for time and travel.

Key Facts about the Marburg Virus:

  • Marburg Virus Disease occurs in sporadic outbreaks primarily in Sub-Saharan Africa.
  • Currently, there are no approved vaccines or treatments for the disease.

Please complete the survey below to express your interest in participating in IAVI's Protocol C104 "A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of the rVSVΔG-MARB-GP Vaccine in Adults in Good General Health".

Thank you!

Loading... Loading...
You have selected an option that triggers this survey to end right now.
To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.